In Vitro Formulation and Evaluation of Preparations Cefixime Nanosuspension

Authors

  • Armaliza Permata Sari Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam
  • Siska Esperanza Sinulingga Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam
  • Ahmad Syukur Hasibuan Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam

DOI:

https://doi.org/10.22270/ajprd.v9i6.1043

Keywords:

Cefixime, nanosuspension, dissolution

Abstract

Objective: To produce a nano-sized cefixime formulation and compare the cefixime formulation with the dissolution test of cefixime from nanosuspension.

Design: Nano-sized cefixime preparations were made with nanosuspension using ethanol and propylene glycol as a solvent and tween 80 as a surfactant. Then the nanosuspension and cefixime suspension were evaluated including organoleptic observations.

Interventions: The intervened variable were formulation an evaluation of cefixime nanosuspension

Main outcome measures: the main measurement in this study was dissolution of cefixime nanosuspension.

Results: The amount of soluble cefixime was measured by having a faster dissolution rate UV spectrophotometer at a wavelength of 285 nm. The average absorbance value of cefixime nanosuspension with propylene glycol solvent was 91.1192 ppm with a concentration of 1.05 nm, nanosuspension with ethanol solvent was 62.4998 ppm with a concentration of 0.72 nm

Conclusion: Nanosuspension with propylene glycol with a very fast dissolution rate. Cefixime can be formulated into nanosuspension preparations using ethanol or propylene glycol as solvent

 

Downloads

Download data is not yet available.

Author Biographies

Armaliza Permata Sari, Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam

Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam

 

Siska Esperanza Sinulingga, Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam

Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam

Ahmad Syukur Hasibuan, Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam

Faculty of Pharmacy Institut Kesehatan Medistra Lubuk Pakam

References

1. Wagh, K.S., Patil, S. K., Akarte, A. K., and Baviskar, D. T. International Journal of Pharmaceutical Sciences Review and Research, 2011; 8(2): 61- 65.
2. Kumar, S., & Singh, P. Various techniques for solubility enhancement: An overview. The Pharma Innovation, 2016; 5(1, Part A), 23.
3. Savjani KT, Gajjar AK, Savjani JS. Drug Solubility: Importance and Enhancement Techniques. ISRN Pharmaceutics Article ID195727, 2012, 1-10, doi:10.5402/2012/195727.
4. Williams J, Naber K, Bryskier A, Høby N, Gould I, Periti P, et al. Classification of oral cephalosporins. A matter for debate. Int J Antimicrob Agents 2001; 17:443-4450. doi:10.1016/s0924- 8579(01)00309-0.
5. Ali T, Mohiuddin OA. In vitro interaction study of cefixime with diclofenac sodium, flurbiprofen, mefenamic acid and tiaprofenic acid. J Chem Pharm Res 2012; 4.
6. Rao NR, Ram P, Kulkarni U. Formulation and evaluation of gas powered system of cefixime tablets for controlled release using hydrophillic polymers. Int J Res Pharm Biomed Sci 2010; 1:82-91.
7. Ramirez E, Laosa O, Guerra P, Duque B, Mosquera B, Borobia AM, et al. Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the biopharmaceutic classification system. Br J Clin Pharm 2010; 70:694-702. doi: 10.1111/j.1365-2125.2010.03757.x
8. Ramirez E, Laosa O, Guerra P, Duque B, Mosquera B, Borobia AM, et al. Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the biopharmaceutic classification system. Br J Clin Pharm 2010; 70:694-702. doi: 10.1111/j.1365-2125.2010.03757.x
9. Mehta, P,. More, A., and Kulkarni, A. Effect of hydrophilic polymers on cefixime complexation with β-cyclodextrin. Int J Curr Pharm Res 2013; 5:66-70.
10. Li, N., Cai, H., Jiang, L., Hu, J., Bains, A., Hu, J., & Gu, Z. Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy. ACS applied materials & interfaces, 2017; 9(8):6865-6877
11. Nayon, M. A. U., Nesa, J., Uddin, M. N., Amran, M. S., & Bushra U. Development and Validation of UV:Spectrometric Method for the Determination of Cefixime Trihydrate in Bulk and Pharmaceutical Formulation. Asian Journal of Biomedical and Pharmaceutical Sciences, 2013;3:(22), 15.

Published

2021-12-15

How to Cite

Sari, A. P., Sinulingga, S. E., & Hasibuan, A. S. (2021). In Vitro Formulation and Evaluation of Preparations Cefixime Nanosuspension. Asian Journal of Pharmaceutical Research and Development, 9(6), 62–64. https://doi.org/10.22270/ajprd.v9i6.1043

Issue

Vol. 9 No. 6 (2021): Vol 9 No 6 (2021): Volume 9 Issue 6 Nov. - Dec. 2021

Section

Research Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).